Advances in Interventional Cardiology
eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current Issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
Share:
Send email
Share:

Transcatheter aortic valve implantation: latest evidence, gaps in knowledge, and future directions

Dario Mafrica
1
,
Artur Dziewierz
2, 3
,
Dobromir Dobrev
4, 5, 6
,
Francesco Pelliccia
1

  1. Department of Cardiovascular Sciences, University Sapienza, Rome, Italy
  2. Clinical Department of Cardiology and Cardiovascular Interventions, University Hospital, Krakow, Poland
  3. Second Department of Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland
  4. Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany
  5. Department of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Montréal, Canada
  6. Department of Integrative Physiology, Baylor College of Medicine, Houston, USA
Adv Interv Cardiol
DOI: https://doi.org/10.5114/aic.2025.158101
Online publish date: 2025/12/21
Article file
- Transcatheter aortic.pdf  [0.47 MB]
Get citation
 
 
1. Otto CM, Newby DE, Hillis GS. Calcific aortic stenosis: a review. JAMA 2024; 332: 2014-6.
2. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016; 374: 1609-20.
3. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019; 380: 1695-705.
4. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 2019; 380: 1706-15.
5. Rosato S, Biancari F, D’Errigo P, et al. One-year outcomes after surgical versus transcatheter aortic valve replacement with newer generation devices. J Clin Med 2021; 10: 3703.
6. Ahmed M, Ahsan A, Tabassum S, et al. Hemodynamic and clinical outcomes with balloon-expandable valves versus self-expanding valves in patients with small aortic annulus undergoing transcatheter aortic valve replacement: a meta-analysis of randomized controlled trials and propensity score matched studies. Int J Cardiol Heart Vasc 2024; 55: 101542.
7. Pilgrim T, Kalesan B, Wenaweser P, et al. Predictors of clinical outcomes in patients with severe aortic stenosis undergoing TAVI: a multistate analysis. Circ Cardiovasc Interv 2012; 5: 856-61.
8. Bellino M, Ferruzzi GJ, Giordano A, et al. Prevalence and prognostic significance of right ventricular dysfunction in patients with severe low-flow, low-gradient aortic stenosis undergoing transcatheter aortic valve replacement. J Am Heart Assoc 2024; 13: e036239.
9. Ferry C, Garin D, Corti R, et al. Predicting one-year outcomes after TAVI: evidence from a two-site Swiss registry. BMC Cardiovasc Disord 2025; 25: 644.
10. Biancari F, D’Errigo P, Barbanti M, et al. Ten-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients: the OBSERVANT study. Int J Cardiol Heart Vasc 2024; 55: 101545.
11. Awad AK, Otmani Z, Aly Yassin MN, Transcatheter versus surgical aortic valve replacement in patients with aortic stenosis with a small aortic annulus: a meta-analysis with reconstructed time to event data. Int J Cardiol Heart Vasc 2024; 56: 101578.
12. Yuan SM, Yuan AH. A comparison of neurological event and mortality rates between transcatheter aortic valve implantation and surgical aortic valve replacement. Adv Interv Cardiol 2023; 19: 202-8.
13. Radico F, Biancari F, D’Ascenzo F, et. Red blood cell transfusion and mortality after transcatheter aortic valve implantation via transapical approach: a propensity-matched comparison from the TRITAVI registry. Int J Cardiol Heart Vasc 2024; 53:
14. 101460.
15. Tanzilli G, Greco C, Pelliccia F, et al. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study). Am J Cardiol 2009; 104: 1357-61.
16. Pelliccia F, Pasceri V, Marazzi G, et al A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention. Am Heart J 2012; 163: 1019-23.
17. Leone PP, Regazzoli D, Pagnesi M, et al. Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry. EuroIntervention 2023; 19: 256-66.
18. Wilczek K, Chodór P, Harpula J, et al. Comparison of outcomes in patients with severe aortic stenosis treated with small and large Medtronic Evolut R and Evolut PRO self-expandable prosthetic valves. Adv Interv Cardiol 2023; 19: 359-66.
19. Walczewski M, Gąsecka A, Witkowski A, et al. Long-term mortality after transcatheter aortic valve implantation for aortic stenosis in immunosuppression-treated patients: a propensity-matched multicentre retrospective registry-based analysis. Adv Interv Cardiol 2023; 19: 251-6.
20. Romagnoli E, Bianchini F, Aurigemma C, et al. Feasibility, safety and clinical impact of a less-invasive totally-endovascular (LITE) technique for transfemoral TAVI: a 1000 patients single-centre experience. Int J Cardiol Heart Vasc 2024; 55: 101523.
21. Frank D, Durand E, Lauck S, et al. A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study. Eur Heart J 2024; 45: 1904-16.
22. Yildirim A, Genc O, Evlice M, et al. Comparative analysis of direct routine left ventricular guidewire pacing and right ventricular pacing: a faster and safer approach to TAVR. Kardiol Pol 2025; 83: 850-60.
23. Grubb KJ, Gada H, Fraser D, et al. Global results from the optimize PRO Study: standardized TAVR technique and care pathway. J Soc Cardiovasc Angiogr Interv 2025; 4: 103515.
24. Al-Kassou B, Al-Shaikh H, Aksoy A, et al. Impact of transradial versus transfemoral access for preprocedural coronary angiography on TAVR-associated complications. Int J Cardiol Heart Vasc 2023; 46 :101205.
25. Sorysz D, Dziewierz A, Gawlik K, et al. Temporal changes in biomarker levels and their association with the early degeneration stage of transcatheter aortic valves in 18F-fluorodeoxyglucose and 18F-sodium fluoride positron emission tomography studies. Adv Interv Cardiol 2024; 20: 329-37.
26. Özderya A, Yerlikaya MG, Aslan AO et al. A new and easy parameter to predict the requirement for permanent pacemaker implantation after transaortic valve implantation: aortic knob calcification. Adv Interv Cardiol 2024; 20: 319-28.
27. de Azevedo Filho AF, Accorsi TA, Ribeiro HB. Coronary artery disease in patients with aortic stenosis and transcatheter aortic valve implantation: implications for management. Eur Cardiol 2021; 16: e49.
28. Pelliccia F, Trani C, Biondi-Zoccai GG, et al. Comparison of the feasibility and effectiveness of transradial coronary angiography via right versus left radial artery approaches (from the PREVAIL Study). Am J Cardiol 2012; 110: 771-5.
29. Marazzi G, Pelliccia F, Campolongo G, et al. Usefulness of nutraceuticals (Armolipid Plus) versus ezetimibe and combination in statin-intolerant patients with dyslipidemia with coronary heart disease. Am J Cardiol 2015; 116: 1798-801.
30. Pelliccia F, Cecchi F, Olivotto I, Camici PG. Microvascular dysfunction in hypertrophic cardiomyopathy. J Clin Med 2022; 11: 6560.
31. Montone RA, Rinaldi R, Niccoli G, et al. Optimizing management of stable angina: a patient-centered approach integrating revascularization, medical therapy, and lifestyle interventions. J Am Coll Cardiol 2024; 84: 744-60.
32. Gragnano F, Moscarella E, Calabrò P, et al. Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry. Intern Emerg Med 2021; 16: 379-87.
33. Ottaviani A, Mansour D, Molinari LV, et al. Revisiting diagnosis and treatment of hypertrophic cardiomyopathy: current practice and novel perspectives. J Clin Med 2023; 12: 5710.
34. Tarantini G, Tang G, Nai Fovino L, et al. Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery. EuroIntervention 2023; 19: 37-52.
35. Praz F, Borger MA, Lanz J, et al. 2025 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2025; 46: 4635-736.
36. Wilimski R, Huczek Z, Krauz K, et al. Impact of previous coronary artery revascularization on outcomes in patients undergoing transcatheter aortic valve implantation. Adv Interv Cardiol 2023; 19: 243-50.
37. Goulden CJ, Wright K, Alim S, et al. Transcatheter aortic valve implantation (TAVI) in bicuspid aortic valve disease: a systematic review. Cardiol Rev 2024 Sep 5. doi: 10.1097/CRD.0000000000000784.
38. Tchétché D, Ziviello F, De Biase C, et al. Transcatheter aortic valve implantation with the Evolut platform for bicuspid aortic valve stenosis: the international, multicentre, prospective BIVOLUTX registry. EuroIntervention 2023; 19: 502-11.
39. Ruck A, Kim WK, Del Sole PA, et al. TAVI with the ACURATE neo2 in severe bicuspid aortic valve stenosis: the Neo2 BAV Registry. EuroIntervention 2025; 21: e130-9.
40. Fiorina C, Massussi M, Ancona M, et al. Mid-term outcomes and hemodynamic performance of transcatheter aortic valve implantation in bicuspid aortic valve stenosis: Insights from the bicuSpid TAvi duraBILITY (STABILITY) registry. Catheter Cardiovasc Interv 2023; 102: 1132-9.
41. Süygün H, Kasapkara HA, Güney MC, et al. Incidence and predictors of permanent pacemaker implantation after transcatheter aortic valve implantation with a balloon-expandable biosprosthesis in patients with bicuspid aortic valves. Adv Interv Cardiol 2024; 20: 311-8.
42. Poletti E, De Backer O, Scotti A, et al. Transcatheter aortic valve replacement for pure native aortic valve regurgitation: the PANTHEON International Project. JACC Cardiovasc Interv 2023; 16: 1974-85.
43. Sá MP, Jacquemyn X, Simonato M, et al. Late survival after valve-in-valve transcatheter aortic valve implantation with balloon- versus self-expandable valves: meta-analysis of reconstructed time-to-event data. Am J Cardiol 2023; 209: 120-7.
44. Giordana F, Bruno F, Conrotto F, et al. Incidence, predictors and outcomes of valve-in-valve TAVI: a systematic review and meta-analysis. Int J Cardiol 2020; 316: 64-9.
45. Sugiyama Y, Moriyama N, Miyashita H, et al. Long-term assessment of survival after transcatheter aortic valve implantation – insights from the international transcatheter aortic valve implantation registry. Circ J 2024; 88: 462-71.
46. Le Ruz R, Leroux L, Lhermusier T, et al. Outcomes of transcatheter aortic valve implantation for native aortic valve regurgitation. Eurointervention 2024; 20: e1076-85.
47. Nishida K, Saji M, Higuchi R, et al. Predictors for all-cause mortality in men after transcatheter aortic valve replacement: a report from the LAPLACE-TAVI registry. Int J Cardiol Heart Vasc 2023; 48: 101257.
48. Özbek K, Dağlı M, Balun A, et al. Increased epicardial adipose tissue volume may adversely affect outcomes in patients undergoing transcatheter aortic valve implantation. Adv Interv Cardiol 2024; 20: 420-7.
49. Błaszkiewicz M, Aleksandrowicz KA, Mazur M, et al. Prevalence of iron deficiency and its influence on six-minute walk test distance in patients eligible for transcatheter aortic valve implantation. A prospective study. Adv Interv Cardiol 2024; 20: 443-8.
50. Zheng HJ, Liu X, Lin DQ, et al. Clinical impact of baseline mitral regurgitation on outcomes after transcatheter aortic valve replacement for severe aortic stenosis. Int J Cardiol Heart Vasc 2024; 50: 101348.
51. Rangel RH, Voran JC, Seoudy H, et al. Transcatheter aortic valve replacement in patients with severe aortic valve stenosis and concomitant mitral valve regurgitation - 5 years follow-up. Int J Cardiol Heart Vasc 2024; 53: 101416.
Copyright: © 2025 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.